Business
Bausch Health Observes Mental Health Awareness Month
LAVAL, QC / ACCESSWIRE / May 10, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is prou...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"Bausch Health Observes Mental Health Awareness MonthLAVAL, QC / ACCESSWIRE / May 10, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is proud to recognize May as Mental Health Awareness Month by continuing efforts that highlight the importance of educating and supporting those with mental health care needs.With more people finding value in speaking with a mental health professional and seeking treatment, this heightened focus on mental health has never been more important.1 By the end of 2022, 37% of Americans rated their mental health as \"fair or poor\"-a 6% increase from 2021. Twenty-six percent expect to experience more stress throughout 2023.2 Dedicating the month of May to mental health offers those with concerns the reminder and opportunity to prioritize self-awareness and self-care.This year, Bausch Health is also proud to highlight 20 years of trusted legacy with WELLBUTRIN XL.3,4 Since its FDA approval in 2003, WELLBUTRIN XL has been prescribed by more than 440,000 healthcare professionals to more than 7 million patients for a total of more than 51 million prescriptions filled.5-7WELLBUTRIN XL offers a proven clinical profile, convenient dosing for patients, and comprehensive support for eligible patients.3 Visit wellbutrinXL.com to access information regarding mental health and depression.About Bausch HealthBausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our healthcare products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our controlling ownership interest in Bausch + Lomb Corporation. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.INDICATIONWELLBUTRIN XL® (bupropion hydrochloride extended-release tablets) is a prescription medicine used to treat adults with a certain type of depression called major depressive disorder, and for the prevention of autumn-winter seasonal depression (seasonal affective disorder).IMPORTANT SAFETY INFORMATIONWARNING: CHANGES IN THINKING AND BEHAVIOR, DEPRESSION, AND SUICIDA...